Bryan R. Cullen

Duke University

$22,732,834

Attributed

$24,951,401

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2005–22

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$24,951,401 · 22

By mechanism

R01$15,086,978 · 8

T32$4,381,017 · 1

R21$2,113,910 · 5

P30$1,993,333 · 3

R56$1,182,500 · 3

P51$193,663 · 2

Top collaborators

J. Victor Garcia-Martinez5 shared
Ronald I Swanstrom5 shared

Most similar at Duke University

Same institution · by research overlap

Nathan A Fitzsimmons$39,514

Others in their field

Top investigators on “Viral”

Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
Judith S. Currier · University Of California Los Angeles$185,434,785
Constance Ann Benson · University Of California, San Diego$165,517,633

Research focus

ViralGrantCellsBaseVirusProteinsIn VivoInfectionHiv-1GenomeRna InterferenceMessenger RnaMicrornasApplications GrantsLightInterestGene ExpressionLeadMalignant NeoplasmsCell LineProgramsPlayPathogenesisGenes

Grant awards (84)

Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse$322,000

R01 · FY2022 · DA · contact PI

Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication$197,385

R21 · FY2022 · AI · contact PI

Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse$322,000

R01 · FY2021 · DA · contact PI

Reversal of epigenetic silencing rescues integrase-deficient HIV-1 replication$237,775

R21 · FY2021 · AI · contact PI

Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse$322,000

R01 · FY2020 · DA · contact PI

Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases$732,425

R01 · FY2019 · AI · contact PI

Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse$321,833

R01 · FY2019 · DA · contact PI

Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases$741,715

R01 · FY2018 · AI · contact PI

Viral Oncology Training Grant$391,340

T32 · FY2018 · CA · contact PI

Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse$319,834

R01 · FY2018 · DA · contact PI

Effect of m6A editing of RNA on influenza A virus replication$198,750

R21 · FY2018 · AI · contact PI

Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases$735,615

R01 · FY2017 · AI · contact PI

Effect of m6A methylation of HIV-1 transcripts on viral replication$397,500

R56 · FY2017 · AI · contact PI

Viral Oncology Training Grant$387,094

T32 · FY2017 · CA · contact PI

Effect of m6A editing of RNA on influenza A virus replication$238,500

R21 · FY2017 · AI · contact PI

Viral Oncology Training Grant$13,628

T32 · FY2017 · CA · contact PI

Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases$712,690

R01 · FY2016 · AI · contact PI

Role and mechanism of action of gamma herpesvirus microRNAs$392,500

R01 · FY2016 · AI · contact PI

Viral Oncology Training Grant$378,220

T32 · FY2016 · CA · contact PI

Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo$172,913

R21 · FY2016 · CA · contact PI

Disruption of latent HIV-1 proviruses using CRISPR/Cas endonucleases$405,406

R01 · FY2015 · AI · contact PI

Role and mechanism of action of gamma herpesvirus microRNAs$392,500

R01 · FY2015 · AI · contact PI

Viral Oncology Training Grant$373,216

T32 · FY2015 · CA · contact PI

Using bacterial CRISPR/Cas endonucleases to selectively eliminate HPV-transformed cells in vivo$207,495

R21 · FY2015 · CA · contact PI

Reconstitution of a protective antiviral RNAi response in somatic human cells$198,542

R21 · FY2015 · AI · contact PI

Role and mechanism of action of gamma herpesvirus microRNAs$392,500

R01 · FY2014 · AI · contact PI

HIV-1: microRNA interactions$380,725

R01 · FY2014 · DA · contact PI

Viral Oncology Training Grant$358,818

T32 · FY2014 · CA · contact PI

Reconstitution of a protective antiviral RNAi response in somatic human cells$235,500

R21 · FY2014 · AI · contact PI

Nucleic Acid Biology$26,331

P30 · FY2014 · CA · contact PI

Role and mechanism of action of gamma herpesvirus microRNAs$368,950

R01 · FY2013 · AI · contact PI

HIV-1: microRNA interactions$365,496

R01 · FY2013 · DA · contact PI

Molecular Virology Core$79,300

P30 · FY2013 · AI · contact PI

Nucleic Acid Biology$16,576

P30 · FY2013 · CA · contact PI

HIV-1: microRNA interactions$380,725

R01 · FY2012 · DA · contact PI

Role and mechanism of action of gamma herpesvirus microRNAs$359,791

R01 · FY2012 · AI · contact PI

Viral Oncology Training Grant$316,972

T32 · FY2012 · CA · contact PI

Molecular Virology Core$185,797

P30 · FY2012 · AI · contact PI

Nucleic Acid Biology$18,171

P30 · FY2012 · CA · contact PI

Nucleic Acid Biology$2,501

P30 · FY2012 · CA · contact PI

Role and mechanism of action of gamma herpesvirus microRNAs$392,500

R56 · FY2011 · AI · contact PI

HIV-1: microRNA interactions$380,725

R01 · FY2011 · DA · contact PI

Viral Oncology Training Grant$311,338

T32 · FY2011 · CA · contact PI

Molecular Virology Core$247,541

P30 · FY2011 · AI · contact PI

Influenza virus small RNAs$193,050

R21 · FY2011 · AI · contact PI

Nucleic Acid Biology$18,993

P30 · FY2011 · CA · contact PI

HIV-1: microRNA interactions$392,500

R01 · FY2010 · DA · contact PI

Function of alpha herpesvirus microRNAs$392,500

R56 · FY2010 · AI · contact PI

Role and mechanism of action of Gamma herpesvirus microRNAs$331,002

R01 · FY2010 · AI · contact PI

Viral Oncology Training Grant$296,458

T32 · FY2010 · CA · contact PI

Influenza virus small RNAs$234,000

R21 · FY2010 · AI · contact PI

Molecular Virology Core$218,396

P30 · FY2010 · AI · contact PI

Nucleic Acid Biology$20,838

P30 · FY2010 · CA · contact PI

Role and mechanism of action of Gamma herpesvirus microRNAs$334,345

R01 · FY2009 · AI · contact PI

Effect of APOBEC3G on retroviruses and retrotransposons$325,465

R01 · FY2009 · AI · contact PI

Viral Oncology Training Grant$318,974

T32 · FY2009 · CA · contact PI

CORE--MOLECULAR VIROLOGY$247,599

P30 · FY2009 · AI · contact PI

Role and mechanism of action of Gamma herpesvirus microRNAs$334,345

R01 · FY2008 · AI · contact PI

Effect of APOBEC3G on retroviruses and retrotransposons$325,465

R01 · FY2008 · AI · contact PI

Viral Oncology Training Grant$318,261

T32 · FY2008 · CA · contact PI

CORE--MOLECULAR VIROLOGY$238,068

P30 · FY2008 · AI · contact PI

MONKEY RHADINOVIRUS, A MONKEY MODEL FOR HUMAN HERPESVIRUS 8$135,175

P51 · FY2008 · RR · contact PI

Molecular Mechanism of HIV-1 Vif Function$365,049

R01 · FY2007 · AI · contact PI

Role and mechanism of action of Gamma herpesvirus microRNAs$340,730

R01 · FY2007 · AI · contact PI

Effect of APOBEC3G on retroviruses and retrotransposons$331,769

R01 · FY2007 · AI · contact PI

Regulation of human microRNA biosynthesis and activity$292,040

R01 · FY2007 · GM · contact PI

CORE--MOLECULAR VIROLOGY$251,295

P30 · FY2007 · AI · contact PI

MONKEY RHADINOVIRUS, A MONKEY MODEL FOR HUMAN HERPESVIRUS 8$58,488

P51 · FY2007 · RR · contact PI

Viral Oncology Training Grant$435,785

T32 · FY2006 · CA · contact PI

Molecular Mechanism of HIV-1 Vif Function$375,953

R01 · FY2006 · AI · contact PI

Role and mechanism of action of Gamma herpesvirus microRNAs$349,782

R01 · FY2006 · AI · contact PI

Effect of APOBEC3G on retroviruses and retrotransposons$342,205

R01 · FY2006 · AI · contact PI

Regulation of human microRNA biosynthesis and activity$300,762

R01 · FY2006 · GM · contact PI

CORE--MOLECULAR VIROLOGY$214,081

P30 · FY2006 · AI · contact PI

Viral Oncology Training Grant$480,913

T32 · FY2005 · CA

Molecular Mechanism of HIV-1 Vif Function$385,000

R01 · FY2005 · AI

Effect of APOBEC3G on retroviruses and retrotransposons$364,480

R01 · FY2005 · AI

Regulation of human microRNA biosynthesis and activity$308,000

R01 · FY2005 · GM

CORE--MOLECULAR VIROLOGY$207,846

P30 · FY2005 · AI

Regulation of human microRNA biosynthesis and activity$246,400

R01 · FY2004 · GM

Molecular Mechanism of HIV-1 Vif Function$231,000

R01 · FY2004 · AI

HIV-1 TROPISM AND CHEMOKINE RECEPTORS$158,318

R01 · FY2002 · AI

HIV-1 TROPISM AND CHEMOKINE RECEPTORS$153,706

R01 · FY2001 · AI

HIV-1 TROPISM AND CHEMOKINE RECEPTORS$149,232

R01 · FY2000 · AI